Medical breakthroughs, including new drug therapies and health technologies, have accelerated in recent years to transform patient care, turning formerly fatal diseases into chronic ones. These innovations are treating some of the rarest diseases and are bringing new tools to doctors and care providers.
The Atlantic explored the state of modern medicine and the science that has revolutionized treatments. We examined the role of personalized medicine and how new treatments can be made accessible to patients.
Watch full session videos
To view photos from this event, please visit our Facebook page
For more information, please contact Grace Harvey at firstname.lastname@example.org
- Tuesday, February 21
- 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
- 8:35 a.m.The DNA of Modern MedicineLaurie Glimcher, President and CEO, Dana-Farber Cancer Institute
With Joie Chen, Contributor, AtlanticLIVE
- 8:55 a.m.On the Frontlines of ScienceStephen Elledge, Gregor Mendel Professor of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women’s Hospital
Julie Wolf-Rodda, Director of Development, Foundation for the National Institutes of Health
Daniel Skovronsky, Senior Vice President, Clinical and Product Development, Eli Lilly and Company
With Ross Andersen, Senior Editor, The Atlantic
- 9:25 a.m.The New Era of Medicine Stephen Ubl, President and CEO, Pharmaceutical Research and Manufacturers of America
With Joe Shortsleeve, Former Chief Correspondent for WBZ-TV, Current Senior Advisor at Liberty Square
*Produced by our underwriter PhRMA
- 9:35 a.m.Funding the Future Noubar Afeyan, CEO, Flagship Pioneering
Tony Coles, CEO, Yumanity Therapeutics
Gilmore O’Neill, Senior Vice President, Late Stage Clinical Development, Biogen
With Joie Chen, AtlanticLIVE
- 10:05 a.m.Making Medicine PersonalRobert Green, Co-Director, BabySeq Project, Brigham and Women’s Hospital and Harvard Medical School
Lauren Stetson, Participant in BabySeq Project
With Ross Andersen, The Atlantic
- 10:35 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE
Also in This Series
Featuring Graham Allison
and Jeffrey Goldberg
Graham Allison, Director of Harvard University's Belfer Center for Science and International Affairs, and author of Destined for War: Can America and China Escape Thucydides’s Trap?, will join The Atlantic’s Editor in Chief Jeffrey Goldberg to explore the US-China relationship and see how war in East Asia can be avoided.
The Next Drugs:
An Atlantic Policy Update on Biosimilars
The Atlantic will convene key stakeholders to discuss the state of and future for biosimilars.